Calumet (CLMT) EBITDA (2023 - 2026)

Calumet (CLMT) has 4 years of EBITDA data on file, last reported at -$171.3 million in Q1 2026.

• EBITDA for Q1 2026 came in at -$171.3 million, down 251.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$13.9 million (up 81.92% YoY), and the FY2025 annual result was $108.7 million, up 1241.98% from the prior year.
• EBITDA eased to -$171.3 million in Q1 2026 per CLMT's latest filing, from -$64.5 million in the prior quarter.
• Over five years, EBITDA peaked at $322.9 million in Q3 2025 and troughed at -$171.3 million in Q1 2026.
• A 4-year average of $10.8 million and a median of -$14.4 million in 2023 frame the typical range for EBITDA.
• On a YoY basis, EBITDA climbed as much as 665.5% in 2025 and fell as far as 1729.03% in 2025.
• A 4-year view of EBITDA shows it stood at -$13.9 million in 2023, then jumped by 263.31% to $22.7 million in 2024, then slumped by 384.14% to -$64.5 million in 2025, then tumbled by 165.58% to -$171.3 million in 2026.
• Business Quant data shows CLMT's EBITDA at -$171.3 million in Q1 2026, -$64.5 million in Q4 2025, and $322.9 million in Q3 2025.